\-\ Texto\\:\\ \ \(0\)\
\-\ n\\/a\ \(127\)\
\-\ this\\ patient\\ is\\ currently\\ undergoing\\ a\\ vaccine\\ trial\\ for\\ prostate\\ cancer\\.\\ \\ he\\ has\\ had\\ no\\ metastatic\\ disease\\ since\\ 2001\\.\ \(0\)\
\-\ plain\\ radiographs\\:\ \(0\)\
\-\ lateral\\ image\\ of\\ the\\ lumbar\\ spine\\ reveals\\ multiple\\ levels\\ of\\ round\\ osteoblastic\\ lesions\\ in\\ the\\ vertebral\\ bodies\\ of\\ the\\ lumbar\\ spine\\.\ \(0\)\
\-\ whole\\ body\\ bone\\ scan\\:\ \(0\)\
\-\ increased\\ radiotracer\\ accumulation\\ in\\ the\\ medial\\ aspect\\ of\\ the\\ right\\ clavicle\\,\\ the\\ right\\ acetabulum\\,\\ right\\ superior\\ ramus\\,\\ left\\ side\\ of\\ t9\\ and\\ right\\ side\\ of\\ l4\\,\\ multiple\\ other\\ areas\\ throughout\\ the\\ spine\\,\\ the\\ right\\ proximal\\ humerus\\,\\ the\\ left\\ femoral\\ neck\\,\\ and\\,\\ possibly\\,\\ the\\ medial\\ aspect\\ of\\ the\\ anterior\\ right\\ first\\ rib\\.\\ \\ there\\ is\\ also\\ a\\ focus\\ of\\ increased\\ tracer\\ in\\ the\\ right\\ occipital\\ region\\.\ \(0\)\
\-\ metastatic\\ prostate\\ cancer\ \(4\)\
\-\ partial\\ list\\ follows\\ \\(and\\ considers\\ intensity\\ of\\ uptake\\)\ \(0\)\
\-\ other\\ cancers\\ resulting\\ in\\ osteoblastic\\ skeletal\\ metastases\\.\\ \ \(0\)\
\-\ multifocal\\ osteomyelitis\ \(3\)\
\-\ fibrous\\ dysplasia\\ \\(polyostotic\\)\ \(0\)\
\-\ hyperparathyroidism\ \(35\)\
\-\ hyperthyroidism\ \(31\)\
\-\ osteomalacia\ \(7\)\
\-\ 55\\ year\\ old\\ male\\ with\\ prostate\\ cancer\\.\ \(1\)\
\-\ prostate\\ cancer\\ is\\ a\\ common\\ cause\\ of\\ osseous\\ metastatic\\ disease\\.\\ \\ \\ \\ tumor\\ may\\ spread\\ through\\ batson\\&\\#8217\\;s\\ venous\\ plexus\\ and\\ via\\ extension\\ through\\ pelvic\\ and\\ para\\-aortic\\ lymph\\ nodes\\.\\ \\ osteoblastic\\ lesions\\ are\\ typical\\,\\ but\\ lytic\\ lesions\\ do\\ sometimes\\ occur\\,\\ resulting\\ in\\ false\\ negative\\ bone\\ scans\\.\\ \\ the\\ relative\\ frequency\\ of\\ skeletal\\ lesions\\ in\\ radiographs\\ is\\ approximately\\ 35\\%\\ compared\\ to\\ 62\\%\\ to\\ 92\\%\\ in\\ osseous\\ scintigraphy\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ prostate\\:\\ 0\\.30059867797135464\ \(0\)\
\-\ osteoblastic\\:\\ 0\\.2603962607954747\ \(0\)\
\-\ cancer\\:\\ 0\\.20671216535004255\ \(0\)\
\-\ the\\:\\ 0\\.20125692625475897\ \(0\)\
\-\ right\\:\\ 0\\.1800617580000217\ \(0\)\
\-\ lesions\\:\\ 0\\.17823504347279395\ \(0\)\
\-\ of\\:\\ 0\\.16701650782513824\ \(0\)\
\-\ spine\\:\\ 0\\.15376043514028\ \(0\)\
\-\ skeletal\\:\\ 0\\.14067152585805182\ \(0\)\
\-\ in\\:\\ 0\\.13510688230817722\ \(0\)\
\-\ resulting\\:\\ 0\\.12912371155691288\ \(0\)\
\-\ metastatic\\:\\ 0\\.1276568097835116\ \(0\)\
\-\ lumbar\\:\\ 0\\.1252995339679156\ \(0\)\
\-\ considers\\:\\ 0\\.1240775754821227\ \(0\)\
\-\ osseous\\:\\ 0\\.12385225228304021\ \(0\)\
\-\ batson\\:\\ 0\\.11464991459798622\ \(0\)\
\-\ side\\:\\ 0\\.10719779166953869\ \(0\)\
\-\ vaccine\\:\\ 0\\.10218722480617558\ \(0\)\
\-\ medial\\:\\ 0\\.10100574943807321\ \(0\)\
\-\ 8217\\:\\ 0\\.10089088821388738\ \(0\)\
\-\ radiographs\\:\\ 0\\.10064304434180799\ \(0\)\
\-\ aspect\\:\\ 0\\.10010789634461677\ \(0\)\
\-\ polyostotic\\:\\ 0\\.09579459282971325\ \(0\)\
\-\ ramus\\:\\ 0\\.09497002282244199\ \(0\)\
\-\ t9\\:\\ 0\\.09497002282244199\ \(0\)\
\-\ through\\:\\ 0\\.09237069417480115\ \(0\)\
\-\ tracer\\:\\ 0\\.08919108469729889\ \(0\)\
\-\ trial\\:\\ 0\\.08636693194557676\ \(0\)\
\-\ list\\:\\ 0\\.08594839924301538\ \(0\)\
\-\ acetabulum\\:\\ 0\\.08514809550374154\ \(0\)\
\-\ is\\:\\ 0\\.08499027247193705\ \(0\)\
\-\ bone\\:\\ 0\\.0846671374450304\ \(0\)\
\-\ increased\\:\\ 0\\.08391009279570176\ \(0\)\
\-\ clavicle\\:\\ 0\\.08367625661056338\ \(0\)\
\-\ false\\:\\ 0\\.08367625661056338\ \(0\)\
\-\ cancers\\:\\ 0\\.0833319030379026\ \(0\)\
\-\ 92\\:\\ 0\\.08234825239138575\ \(0\)\
\-\ whole\\:\\ 0\\.08143096737203608\ \(0\)\
\-\ other\\:\\ 0\\.08058374663396005\ \(0\)\
\-\ scintigraphy\\:\\ 0\\.08057165599311818\ \(0\)\
\-\ and\\:\\ 0\\.0801614185705649\ \(0\)\
\-\ follows\\:\\ 0\\.07591613928530057\ \(0\)\
\-\ multiple\\:\\ 0\\.07589841279334758\ \(0\)\
\-\ accumulation\\:\\ 0\\.07496461575924948\ \(0\)\
\-\ l4\\:\\ 0\\.07407532918449729\ \(0\)\
\-\ 62\\:\\ 0\\.0739042421537661\ \(0\)\
\-\ frequency\\:\\ 0\\.07373528048277123\ \(0\)\
\-\ humerus\\:\\ 0\\.07324063544054371\ \(0\)\
\-\ possibly\\:\\ 0\\.07292059150724926\ \(0\)\
\-\ sometimes\\:\\ 0\\.07260790556147792\ \(0\)\
\-\ rib\\:\\ 0\\.07086921324609194\ \(0\)\
\-\ undergoing\\:\\ 0\\.07046717689437597\ \(0\)\
\-\ plexus\\:\\ 0\\.06994897175686762\ \(0\)\
\-\ spread\\:\\ 0\\.06969708975093404\ \(0\)\
\-\ relative\\:\\ 0\\.06873376763969138\ \(0\)\
\-\ bodies\\:\\ 0\\.06794343183021857\ \(0\)\
\-\ radiotracer\\:\\ 0\\.06772580735380822\ \(0\)\
\-\ scans\\:\\ 0\\.0675116101773038\ \(0\)\
\-\ osteomyelitis\\:\\ 0\\.0668885437015608\ \(0\)\
\-\ 55\\:\\ 0\\.06668704017003252\ \(0\)\
\-\ occipital\\:\\ 0\\.06639027407847115\ \(0\)\
\-\ nodes\\:\\ 0\\.06590961488796926\ \(0\)\
\-\ focus\\:\\ 0\\.06572200860870218\ \(0\)\
\-\ lytic\\:\\ 0\\.06535438515935643\ \(0\)\
\-\ disease\\:\\ 0\\.06513604530124134\ \(0\)\
\-\ do\\:\\ 0\\.06430761959863474\ \(0\)\
\-\ round\\:\\ 0\\.06357223836737595\ \(0\)\
\-\ via\\:\\ 0\\.06341408263647147\ \(0\)\
\-\ metastases\\:\\ 0\\.06272429451072838\ \(0\)\
\-\ compared\\:\\ 0\\.06272429451072838\ \(0\)\
\-\ 35\\:\\ 0\\.06221097926707271\ \(0\)\
\-\ levels\\:\\ 0\\.06150972914432619\ \(0\)\
\-\ pelvic\\:\\ 0\\.06064902298105547\ \(0\)\
\-\ lymph\\:\\ 0\\.060331963411921034\ \(0\)\
\-\ typical\\:\\ 0\\.059960997518716294\ \(0\)\
\-\ partial\\:\\ 0\\.05977924105535047\ \(0\)\
\-\ uptake\\:\\ 0\\.05965940556997497\ \(0\)\
\-\ currently\\:\\ 0\\.059599881450443065\ \(0\)\
\-\ dysplasia\\:\\ 0\\.059422856310207085\ \(0\)\
\-\ vertebral\\:\\ 0\\.05924810564589018\ \(0\)\
\-\ reveals\\:\\ 0\\.059018543409886784\ \(0\)\
\-\ femoral\\:\\ 0\\.057665416590605915\ \(0\)\
\-\ throughout\\:\\ 0\\.057060817517027594\ \(0\)\
\-\ occur\\:\\ 0\\.057060817517027594\ \(0\)\
\-\ since\\:\\ 0\\.05620150613810969\ \(0\)\
\-\ venous\\:\\ 0\\.055393273958153924\ \(0\)\
\-\ intensity\\:\\ 0\\.055091490810244725\ \(0\)\
\-\ extension\\:\\ 0\\.05492200276530273\ \(0\)\
\-\ left\\:\\ 0\\.052932839741053096\ \(0\)\
\-\ cause\\:\\ 0\\.05285547366942786\ \(0\)\
\-\ areas\\:\\ 0\\.0526757981423416\ \(0\)\
\-\ first\\:\\ 0\\.05235824505047976\ \(0\)\
\-\ plain\\:\\ 0\\.0511893214705477\ \(0\)\
\-\ body\\:\\ 0\\.05106190845819156\ \(0\)\
\-\ superior\\:\\ 0\\.05044215479852762\ \(0\)\
\-\ image\\:\\ 0\\.04961936680758445\ \(0\)\
\-\ approximately\\:\\ 0\\.04950578585856215\ \(0\)\
\-\ proximal\\:\\ 0\\.04847159366559948\ \(0\)\
\-\ negative\\:\\ 0\\.04803322193328782\ \(0\)\
\-\ neck\\:\\ 0\\.04746176160656193\ \(0\)\
\-\ region\\:\\ 0\\.04640868937350301\ \(0\)\
\-\ scan\\:\\ 0\\.04603116134355658\ \(0\)\
\-\ he\\:\\ 0\\.04594383366247064\ \(0\)\
\-\ common\\:\\ 0\\.044000386707805456\ \(0\)\
\-\ anterior\\:\\ 0\\.043319722895057707\ \(0\)\
\-\ tumor\\:\\ 0\\.04058219895263198\ \(0\)\
\-\ may\\:\\ 0\\.03904393278146299\ \(0\)\
\-\ to\\:\\ 0\\.03879290497169272\ \(0\)\
\-\ had\\:\\ 0\\.038656406863897354\ \(0\)\
\-\ lateral\\:\\ 0\\.03850443612528661\ \(0\)\
\-\ but\\:\\ 0\\.03836660570982534\ \(0\)\
\-\ also\\:\\ 0\\.03649442818600531\ \(0\)\
\-\ has\\:\\ 0\\.03543921577435045\ \(0\)\
\-\ male\\:\\ 0\\.03454445860267763\ \(0\)\
\-\ there\\:\\ 0\\.030871395554005854\ \(0\)\
\-\ are\\:\\ 0\\.02944051761196912\ \(0\)\
\-\ this\\:\\ 0\\.026660090976293647\ \(0\)\
\-\ patient\\:\\ 0\\.02523496735503925\ \(0\)\
\-\ no\\:\\ 0\\.025230220804788765\ \(0\)\
\-\ year\\:\\ 0\\.023910606960958054\ \(0\)\
\-\ for\\:\\ 0\\.023515848316369634\ \(0\)\
\-\ old\\:\\ 0\\.022962459544522636\ \(0\)\
\-\ with\\:\\ 0\\.015192390922615085\ \(0\)\
